1
|
Khalifian S, Brazio PS, Mohan R, Shaffer
C, Brandacher G, Barth RN and Rodriguez ED: Facial transplantation:
The first 9 years. Lancet. 384:2153–2163. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zuo KJ and Olson JL: The evolution of
functional hand replacement: From iron prostheses to hand
transplantation. Plast Surg (Oakv). 22:44–51. 2014. View Article : Google Scholar :
|
3
|
Bamoulid J, Staeck O, Halleck F,
Khadzhynov D, Brakemeier S, Durr M and Budde K: The need for
minimization strategies: Current problems of immunosuppression.
Transpl Int. 28:891–900. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kuo YR, Chen CC, Chen YC and Chien CM:
Recipient Adipose-derived stem cells enhance recipient cell
engraftment and prolong allotransplant survival in a miniature
swine hind-limb model. Cell Transplant. 26:1418–1427. 2017.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Plock JA, Schnider JT, Zhang W, Schweizer
R, Tsuji W, Kostereva N, Fanzio PM, Ravuri S, Solari MG, Cheng HY,
et al: Adipose- and bone marrow-derived mesenchymal stem cells
prolong graft survival in vascularized composite
allotransplantation. Transplantation. 99:1765–1773. 2015.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Munir H and McGettrick HM: Mesenchymal
stem cell therapy for autoimmune disease: Risks and rewards. Stem
Cells Dev. 24:2091–2100. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Boltze J, Arnold A, Walczak P, Jolkkonen
J, Cui L and Wagner DC: The dark side of the force-constraints and
complications of cell therapies for stroke. Front Neurol.
6:1552015. View Article : Google Scholar
|
8
|
Cui L, Yin S, Liu W, Li N, Zhang W and Cao
Y: Expanded adipose-derived stem cells suppress mixed lymphocyte
reaction by secretion of prostaglandin E2. Tissue Eng.
13:1185–1195. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Crop MJ, Baan CC, Korevaar SS, Ijzermans
JN, Pescatori M, Stubbs AP, van Ijcken WF, Dahlke MH, Eggenhofer E,
Weimar W and Hoogduijn MJ: Inflammatory conditions affect gene
expression and function of human adipose tissue-derived mesenchymal
stem cells. Clin Exp Immunol. 162:474–486. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kuo YR, Chen CC, Goto S, Lin PY, Wei FC
and Chen CL: Mesenchymal stem cells as immunomodulators in a
vascularized composite allotransplantation. Clin Dev Immunol.
2012.854846:2012.
|
11
|
Zhao Q, Ren H and Han Z: Mesenchymal stem
cells: Immunomodulatory capability and clinical potential in immune
diseases. J Cell Immunotherapy. 2:3–20. 2016. View Article : Google Scholar
|
12
|
Bunnell BA, Flaat M, Gagliardi C, Patel B
and Ripoll C: Adipose-derived stem cells: Isolation, expansion and
differentiation. Methods. 45:115–120. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
14
|
Hwang GS, Hu S, Lin YH, Chen ST, Tang TK,
Wang PS and Wang SW: Arecoline inhibits interleukin-2 secretion in
Jurkat cells by decreasing the expression of alpha7-nicotinic
acetylcho-line receptors and prostaglandin E2. J Physiol Pharmacol.
64:535–543. 2013.PubMed/NCBI
|
15
|
Liu Z, Fan H and Jiang S: CD4(+) T-cell
subsets in transplantation. Immunol Rev. 252:183–191. 2013.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Yap M, Brouard S, Pecqueur C and Degauque
N: Targeting CD8 T-cell metabolism in transplantation. Front
Immunol. 6:5472015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Gonzalez-Rey E, Gonzalez MA, Varela N,
O'Valle F, Hernandez-Cortes P, Rico L, Büscher D and Delgado M:
Human adipose-derived mesenchymal stem cells reduce inflammatory
and T cell responses and induce regulatory T cells in vitro in
rheumatoid arthritis. Ann Rheum Dis. 69:241–248. 2010. View Article : Google Scholar
|
18
|
Matula Z, Németh A, Lőrincz P, Szepesi Á,
Brózik A, Buzás EI, Lőw P, Német K, Uher F and Urbán VS: The role
of extracellular vesicle and tunneling Nanotube-mediated
intercellular cross-talk between mesenchymal stem cells and human
peripheral T cells. Stem Cells Dev. 25:1818–1832. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mousavi Niri N, Jaberipour M, Razmkhah M,
Ghaderi A and Habibagahi M: Mesenchymal stem cells do not suppress
lymphoblastic leukemic cell line proliferation. Iran J Immunol.
6:186–194. 2009.
|
20
|
Bronk CC, Yoder S, Hopewell EL, Yang S,
Celis E, Yu XZ and Beg AA: NF-κB is crucial in proximal T-cell
signaling for calcium influx and NFAT activation. Eur J Immunol.
44:3741–3746. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Reale C, Zotti T, Scudiero I, Vito P and
Stilo R: Chapter nine-the NF-κB family of transcription factors and
its role in thyroid physiology. Vitamins and Hormones. Litwack G:
Academic Press; pp. 195–210. 2018, View Article : Google Scholar
|
22
|
Letourneau PA, Menge TD, Wataha KA, Wade
CE, S Cox C Jr, Holcomb JB and Pati S: Human bone marrow derived
mesenchymal stem cells regulate Leukocyte-endothelial interactions
and activation of transcription factor NF-Kappa B. J Tissue Sci
Eng. 3(Suppl): S0012011.
|
23
|
Onishi R, Ohnishi S, Higashi R, Watari M,
Yamahara K, Okubo N, Nakagawa K, Katsurada T, Suda G, Natsuizaka M,
et al: Human amnion-derived mesenchymal stem cell transplantation
ameliorates dextran sulfate sodium-induced severe colitis in rats.
Cell Transplant. 24:2601–2614. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wang PP, Xie DY, Liang XJ, Peng L, Zhang
GL, Ye YN, Xie C and Gao ZL: HGF and direct mesenchymal stem cells
contact synergize to inhibit hepatic stellate cells activation
through TLR4/NF-kB pathway. PLoS One. 7:e434082012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Plumas J, Chaperot L, Richard MJ, Molens
JP, Bensa JC and Favrot MC: Mesenchymal stem cells induce apoptosis
of activated T cells. Leukemia. 19:1597–1604. 2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Akiyama K, Chen C, Wang D, Xu X, Qu C,
Yamaza T, Cai T, Chen W, Sun L and Shi S:
Mesenchymal-stem-cell-induced immunoregulation involves
FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell.
10:544–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Benvenuto F, Ferrari S, Gerdoni E,
Gualandi F, Frassoni F, Pistoia V, Mancardi G and Uccelli A: Human
mesenchymal stem cells promote survival of T cells in a quiescent
state. Stem Cells. 25:1753–1760. 2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ramasamy R, Lam EW, Soeiro I, Tisato V,
Bonnet D and Dazzi F: Mesenchymal stem cells inhibit proliferation
and apoptosis of tumor cells: Impact on in vivo tumor growth.
Leukemia. 21:304–310. 2007. View Article : Google Scholar
|
29
|
Gu YZ, Xue Q, Chen YJ, Yu GH, Qing MD,
Shen Y, Wang MY, Shi Q and Zhang XG: Different roles of PD-L1 and
FasL in immunomodulation mediated by human placenta-derived
mesenchymal stem cells. Hum Immunol. 74:267–276. 2013. View Article : Google Scholar
|
30
|
Zheng JH, Viacava Follis A, Kriwacki RW
and Moldoveanu T: Discoveries and controversies in BCL-2
protein-mediated apoptosis. FEBS J. 283:2690–2700. 2016. View Article : Google Scholar
|
31
|
Lee SH, Park SW, Pyo CW, Yoo NK, Kim J and
Choi SY: Requirement of the JNK-associated Bcl-2 pathway for human
lactoferrin-induced apoptosis in the Jurkat leukemia T cell line.
Biochimie. 91:102–108. 2009. View Article : Google Scholar
|
32
|
Kapur SK and Katz AJ: Review of the
adipose derived stem cell secretome. Biochimie. 95:2222–2228. 2013.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Wang J, Guan E, Roderiquez G and Norcross
MA: Synergistic induction of apoptosis in primary CD4(+) T cells by
macrophage-tropic HIV-1 and TGF-beta1. J Immunol. 167:3360–3366.
2001. View Article : Google Scholar : PubMed/NCBI
|
34
|
Tan J, Wu W, Xu X, Liao L, Zheng F,
Messinger S, Sun X, Chen J, Yang S, Cai J, Gao X, et al: Induction
therapy with autologous mesenchymal stem cells in living-related
kidney transplants: A randomized controlled trial. JAMA.
307:1169–1177. 2012. View Article : Google Scholar : PubMed/NCBI
|
35
|
Reinders ME, de Fijter JW, Roelofs H,
Bajema IM, de Vries DK, Schaapherder AF, Claas FH, van Miert PP,
Roelen DL, van Kooten C, et al: Autologous bone marrow-derived
mesen-chymal stromal cells for the treatment of allograft rejection
after renal transplantation: Results of a phase I study. Stem Cells
Transl Med. 2:107–111. 2013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Peng Y, Ke M, Xu L, Liu L, Chen X, Xia W,
Li X, Chen Z, Ma J, Liao D, et al: Donor-derived mesenchymal stem
cells combined with low-dose tacrolimus prevent acute rejection
after renal transplantation: A clinical pilot study.
Transplantation. 95:161–168. 2013. View Article : Google Scholar
|